The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer

Obesity is a multifactorial and complex condition that is characterized by abnormal and excessive white adipose tissue accumulation, which can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, nonalcoholic fatty liver disease, cardiovascular diseases, and several types...

Full description

Bibliographic Details
Main Authors: Gabriella Simões Heyn, Luís Henrique Corrêa, Kelly Grace Magalhães
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2020.563816/full
_version_ 1818260213409513472
author Gabriella Simões Heyn
Luís Henrique Corrêa
Kelly Grace Magalhães
author_facet Gabriella Simões Heyn
Luís Henrique Corrêa
Kelly Grace Magalhães
author_sort Gabriella Simões Heyn
collection DOAJ
description Obesity is a multifactorial and complex condition that is characterized by abnormal and excessive white adipose tissue accumulation, which can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, nonalcoholic fatty liver disease, cardiovascular diseases, and several types of cancer. Obesity is characterized by excessive adipose tissue accumulation and associated with alterations in immunity, displaying a chronic low-grade inflammation profile. Adipose tissue is a dynamic and complex endocrine organ composed not only by adipocytes, but several immunological cells, which can secrete hormones, cytokines and many other factors capable of regulating metabolic homeostasis and several critical biological pathways. Remarkably, adipose tissue is a major source of circulating microRNAs (miRNAs), recently described as a novel form of adipokines. Several adipose tissue–derived miRNAs are deeply associated with adipocytes differentiation and have been identified with an essential role in obesity-associated inflammation, insulin resistance, and tumor microenvironment. During obesity, adipose tissue can completely change the profile of the secreted miRNAs, influencing circulating miRNAs and impacting the development of different pathological conditions, such as obesity, metabolic syndrome, and cancer. In this review, we discuss how miRNAs can act as epigenetic regulators affecting adipogenesis, adipocyte differentiation, lipid metabolism, browning of the white adipose tissue, glucose homeostasis, and insulin resistance, impacting deeply obesity and metabolic diseases. Moreover, we characterize how miRNAs can often act as oncogenic and tumor suppressor molecules, significantly modulating cancer establishment and progression. Furthermore, we highlight in this manuscript how adipose tissue–derived miRNAs can function as important new therapeutic targets.
first_indexed 2024-12-12T18:27:46Z
format Article
id doaj.art-316c1fcad25a4970b4e189e6b1a87844
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-12T18:27:46Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-316c1fcad25a4970b4e189e6b1a878442022-12-22T00:15:59ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922020-10-011110.3389/fendo.2020.563816563816The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and CancerGabriella Simões HeynLuís Henrique CorrêaKelly Grace MagalhãesObesity is a multifactorial and complex condition that is characterized by abnormal and excessive white adipose tissue accumulation, which can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, nonalcoholic fatty liver disease, cardiovascular diseases, and several types of cancer. Obesity is characterized by excessive adipose tissue accumulation and associated with alterations in immunity, displaying a chronic low-grade inflammation profile. Adipose tissue is a dynamic and complex endocrine organ composed not only by adipocytes, but several immunological cells, which can secrete hormones, cytokines and many other factors capable of regulating metabolic homeostasis and several critical biological pathways. Remarkably, adipose tissue is a major source of circulating microRNAs (miRNAs), recently described as a novel form of adipokines. Several adipose tissue–derived miRNAs are deeply associated with adipocytes differentiation and have been identified with an essential role in obesity-associated inflammation, insulin resistance, and tumor microenvironment. During obesity, adipose tissue can completely change the profile of the secreted miRNAs, influencing circulating miRNAs and impacting the development of different pathological conditions, such as obesity, metabolic syndrome, and cancer. In this review, we discuss how miRNAs can act as epigenetic regulators affecting adipogenesis, adipocyte differentiation, lipid metabolism, browning of the white adipose tissue, glucose homeostasis, and insulin resistance, impacting deeply obesity and metabolic diseases. Moreover, we characterize how miRNAs can often act as oncogenic and tumor suppressor molecules, significantly modulating cancer establishment and progression. Furthermore, we highlight in this manuscript how adipose tissue–derived miRNAs can function as important new therapeutic targets.https://www.frontiersin.org/article/10.3389/fendo.2020.563816/fullmiRNAadipose tissueobesitycancermetabolic syndrome
spellingShingle Gabriella Simões Heyn
Luís Henrique Corrêa
Kelly Grace Magalhães
The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
Frontiers in Endocrinology
miRNA
adipose tissue
obesity
cancer
metabolic syndrome
title The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
title_full The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
title_fullStr The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
title_full_unstemmed The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
title_short The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer
title_sort impact of adipose tissue derived mirnas in metabolic syndrome obesity and cancer
topic miRNA
adipose tissue
obesity
cancer
metabolic syndrome
url https://www.frontiersin.org/article/10.3389/fendo.2020.563816/full
work_keys_str_mv AT gabriellasimoesheyn theimpactofadiposetissuederivedmirnasinmetabolicsyndromeobesityandcancer
AT luishenriquecorrea theimpactofadiposetissuederivedmirnasinmetabolicsyndromeobesityandcancer
AT kellygracemagalhaes theimpactofadiposetissuederivedmirnasinmetabolicsyndromeobesityandcancer
AT gabriellasimoesheyn impactofadiposetissuederivedmirnasinmetabolicsyndromeobesityandcancer
AT luishenriquecorrea impactofadiposetissuederivedmirnasinmetabolicsyndromeobesityandcancer
AT kellygracemagalhaes impactofadiposetissuederivedmirnasinmetabolicsyndromeobesityandcancer